Skip to main content
BrainCited

Uridine Monophosphate Neurotransmitter Imbalance

C

The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Duridine\u002Dmonophosphate\u0026condition\u003Dneurotransmitter\u002Dimbalance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

結論

The uridine + DHA + choline combination (known as the 'Mr. Happy Stack') provides synergistic support for phospholipid synthesis and dopamine receptor expression. Limited but promising clinical evidence.

Key Study Findings

Observational Study
Combining Metabolomics and Proteomics to Reveal Key Serum Compounds Related to Canine Intervertebral Disc Herniation.
Dose: None vs: None Outcome: None 効果: None None

対象集団: Dogs with intervertebral disc herniation

In Vitro
The Effects of Semen Ziziphi Spinosae Extract on LPS-Induced Astrocyte Gene Expression and Metabolites.
Dose: None vs: LPS-treated astrocyte controls Outcome: Astrocyte gene expression and metabolite changes 効果: None None

対象集団: LPS-induced inflammatory astrocyte model

Review
Involvement of uridine in brain and gut health: insights into its neuroprotective potential via the …
Dose: None vs: None Outcome: None 効果: None None

対象集団: None

Other
1H and 31P magnetic resonance spectroscopy reveals potential pathogenic and biomarker metabolite alterations in Lafora …
Dose: None vs: None Outcome: None 効果: None P = 0.013

対象集団: Healthy adults

Other 4 weeks
Jujuboside A Regulates Calcium Homeostasis and Structural Plasticity to Alleviate Depression-Like Behavior via Shh Signaling …
Dose: 5 mg/kg vs: None Outcome: Cognitive function 効果: None None

対象集団: Sprague Dawley rats

Key Statistics

4

研究数

300

参加者数

Positive

C

グレード

Referenced Papers

Aging and disease 2023 9 件の引用
Clinical pharmacokinetics 2018 128 件の引用
Autonomic neuroscience : … 2015 81 件の引用
European journal of … 2011 16 件の引用
Annual review of … 2009 141 件の引用
The European journal … 2007 55 件の引用
Molecular and chemical … 1996 17 件の引用
Journal of neuroscience … 1996 16 件の引用
Behavioural brain research 1995 146 件の引用
Journal of steroid … 1984 22 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
150-250 mg/day
cognitivesupport:
250-500 mg sublingually

上限量: Not established; well-tolerated up to 1,000 mg/day

研究で検討された用量

用量 期間 効果 N
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Neutral --
5 mg/kg 4 weeks Positive --
1 g -- Mixed --
None -- Mixed --
None -- Mixed --

推奨摂取タイミング: Morning; synergizes with DHA and choline sources

Safety & Side Effects

報告されている副作用

  • Mild gastrointestinal discomfort
  • Headache (rare)
  • Nervousness at high doses

既知の相互作用

  • No significant drug interactions established

耐容上限摂取量: Not established; well-tolerated up to 1,000 mg/day

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Uridine Monophosphate help with Neurotransmitter Imbalance?
Based on 4 studies with 300 participants, there is limited but promising evidence that Uridine Monophosphate may support Neurotransmitter Imbalance management. Our evidence grade is C (Some Evidence).
How much Uridine Monophosphate should I take for Neurotransmitter Imbalance?
Studies have used various dosages. A commonly studied range is 150-250 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Uridine Monophosphate?
Reported side effects may include Mild gastrointestinal discomfort, Headache (rare), Nervousness at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Uridine Monophosphate and Neurotransmitter Imbalance?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

に関する他の成分: Neurotransmitter Imbalance

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。